Hertility Health
At-home hormone and fertility insights
- 21-100 employees
- Healthcare
- B2C
- SaaS
- Femtech
- Biotechnology
- Marylebone, London, UK
Jump to section
Company mission
To give women a visually clear image of their digital biological clock & reproductive biology with actionable advice and pathways to care.
0% employee growth in 12 months
Our take
The women's health system has traditionally been flawed, and women are being failed far too often. 88% of the female egg reserves are gone by the age of 30 and 1 in 7 couples experience infertility. Hertility is leading the revolution in reproductive health through its easy to administer, at home hormone & fertility testing system.
Hertility offers quick results and helps users save up to £1,800 on private tests. Trusted by NICE, the Endocrine Society, the Royal College of Obstetricians & Gynaecologists and the American Society for Reproductive Medicine, Hertility is giving all women the fundamental right to understand their own fertility.
Last year the global market for female-focused health products generated $820.6 million, and is estimated to reach at least $3 billion by the end of 2030. Within an industry on the rise, Hertility has unique growth opportunities as the only CQC-approved provider of at-home fertility testing.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- 33 days paid holidays, including public holidays
- Equity options - The company's growth and success is shared with all employees
- Covering maternity/ paternity/ adoption leave & progressive health leave policies covering menstruation and menopause
- Invest in your future; 5% pension scheme matched by 4% employee contribution
- All Hertility employees are eligible to receive free Hertility kits; discounted Hertility products for family and friends and fertility counselling with our fertility counsellor
- You are entitled to receive 3 free counselling sessions per year with our in-house fertility counsellor and Psychotherapist
Funding (1 round)
Jun 2021
$5.3m
SEED
Total funding: $5.3m
This company has top investors
Leadership
Dr Natalie Getreu
(COO)Natalie worked for the NHS in Organ Transplant and Fertility Treatment alongside serving as a teaching and research fellow at UCL. In February 2019, she co-founded Hertility Health, and has served as COO since.
Deirdre O'Neill
(CCO & Legal Officer)After her qualification as a solicitor, Deirdre worked at Osbournes, McClure Naismith, and Marriott Harrison. She left her Associate position at Cooley in October 2019, having co-founded Hertility Health in June earlier that year.
Helen O'Neill
(CEO)Helen's academic research is focused on the use of CRISPR genome editing and base editing for the potential treatment of disorders and is one of three female co-founders at Hertility Health.